- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · May 4, 2026 | 34.35M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 49.39M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 45.6M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 38.6M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 34.56M sh |
| Capex | Q3 2026 · Mar 31, 2026 | $26K |
| Capex | Q3 2026 · Mar 31, 2025 | $18K |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | −$11.58M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2025 | −$15.38M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $184.76M |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $97.74M |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | $183.33M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $187.36M |
| Stockholders Equity | Q3 2026 · Sep 30, 2025 | $93.6M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $97.3M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $97.57M |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | $75.94M |
| Stockholders Equity | Q3 2026 · Sep 30, 2024 | $64.18M |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | $47.25M |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $3.27M |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $1.8M |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $3.67M |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $2.3M |
| Current Assets | Q3 2026 · Mar 31, 2026 | $186.02M |
| Current Assets | Q3 2026 · Jun 30, 2025 | $98.52M |
| Total Assets | Q3 2026 · Mar 31, 2026 | $187M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $99.59M |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$0.24 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$0.72 |
| Eps Diluted restated | Q3 2026 · Mar 31, 2025 | −$0.38 |
| Eps Diluted restated | Q3 2026 · Mar 31, 2025 | −$0.84 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$0.24 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$0.72 |
| Eps Basic restated | Q3 2026 · Mar 31, 2025 | −$0.38 |
| Eps Basic restated | Q3 2026 · Mar 31, 2025 | −$0.84 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $7.28M |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $21.26M |
| Sga Expense restated | Q3 2026 · Mar 31, 2025 | $8.84M |
| Sga Expense restated | Q3 2026 · Mar 31, 2025 | $16.47M |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $6.3M |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $15.5M |
| Rd Expense restated | Q3 2026 · Mar 31, 2025 | $6.5M |
| Rd Expense restated | Q3 2026 · Mar 31, 2025 | $15.47M |
| Net Income | Q3 2026 · Mar 31, 2026 | −$11.94M |
| Net Income | Q3 2026 · Mar 31, 2026 | −$32.74M |
| Net Income | Q3 2026 · Dec 31, 2025 | −$11.84M |
| Net Income | Q3 2026 · Sep 30, 2025 | −$8.97M |
| Net Income restated | Q3 2026 · Mar 31, 2025 | −$14.5M |
| Net Income restated | Q3 2026 · Mar 31, 2025 | −$29.11M |
| Net Income restated | Q3 2026 · Dec 31, 2024 | −$9.55M |
| Net Income | Q3 2026 · Sep 30, 2024 | −$5.06M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$13.58M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$36.76M |
| Operating Income restated | Q3 2026 · Mar 31, 2025 | −$15.34M |
| Operating Income restated | Q3 2026 · Mar 31, 2025 | −$31.93M |
| Revenue | Q3 2026 · Mar 31, 2026 | $0 |
| Revenue | Q3 2026 · Mar 31, 2026 | $0 |
| Revenue | Q3 2026 · Mar 31, 2025 | $0 |
| Revenue | Q3 2026 · Mar 31, 2025 | $0 |